These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 32980433)

  • 1. Long term outcome after treatment of de novo coronary artery lesions using three different drug coated balloons.
    Venetsanos D; Omerovic E; Sarno G; Pagonis C; Witt N; Calais F; Böhm F; Jurga J; Völz S; Koul S; Olivercrona G; James S; Alfredsson J
    Int J Cardiol; 2021 Feb; 325():30-36. PubMed ID: 32980433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term efficacy of drug coated balloons compared with new generation drug-eluting stents for the treatment of de novo coronary artery lesions.
    Venetsanos D; Lawesson SS; Panayi G; Tödt T; Berglund U; Swahn E; Alfredsson J
    Catheter Cardiovasc Interv; 2018 Nov; 92(5):E317-E326. PubMed ID: 29481718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SeQuent Please vs. Pantera Lux drug coated balloon angioplasty in real life: Results from the Düsseldorf DCB registry.
    Assadi-Schmidt A; Mohring A; Liebsch E; Dannenberg L; Achilles A; Pöhl M; Afzal S; Veulemans V; Horn P; Sansone R; Bönner F; Levkau B; Kelm M; Zeus T; Polzin A
    Int J Cardiol; 2017 Mar; 231():68-72. PubMed ID: 28089147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of clinical outcomes of two different types of paclitaxel-coated balloons for treatment of patients with coronary in-stent restenosis.
    Nguyen VPT; Kim C; Hong SJ; Ahn CM; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Heart Vessels; 2019 Sep; 34(9):1420-1428. PubMed ID: 30903315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between drug-coated balloon angioplasty and second-generation drug-eluting stent placement for the treatment of in-stent restenosis after drug-eluting stent implantation.
    Kang IS; Shehata I; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Heart Vessels; 2016 Sep; 31(9):1405-11. PubMed ID: 26337620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes of drug-coated balloon in coronary lesions: a real-world, all-comers study.
    Pan L; Lu W; Han Z; Pan S; Wang X; Shan Y; Wang X; Zheng X; Li R; Zhou Y; Qin P; Shi Q; Zhou S; Zhang W; Guo S; Zhang P; Qin X; Sun G; Qin Z; Huang Z; Qiu C
    Clin Res Cardiol; 2022 Jul; 111(7):732-741. PubMed ID: 34313800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of 2 Different Drug-Coated Balloons in In-Stent Restenosis: The RESTORE ISR China Randomized Trial.
    Chen Y; Gao L; Qin Q; Chen S; Zhang J; Chen H; Wang L; Jin Z; Zheng Y; Zhang Z; Li H; Li X; Fu G; Chen L; Sun Z; Wang Y; Jin Q; Cao F; Guo J; Zhao Y; Guan C; Li W; Xu B;
    JACC Cardiovasc Interv; 2018 Dec; 11(23):2368-2377. PubMed ID: 30522665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Follow-Up After Treatment of Drug-Eluting Stent Restenosis and De Novo Lesions Using SeQuent Please Paclitaxel-Coated Balloons.
    Zhang D; Sun Y; Liu X; Liu F; Cheng Y; Ma X; Zhao Y; Zhou Y
    Angiology; 2019 May; 70(5):414-422. PubMed ID: 30384776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-coated balloons versus drug-eluting stents for coronary de novo lesions in dialysis patients.
    Funayama N; Muratsubaki S; Ito R; Tobisawa T; Konishi T
    Heart Vessels; 2023 Mar; 38(3):300-308. PubMed ID: 36045267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A propensity score matched comparative study between paclitaxel-coated balloon and everolimus-eluting stents for the treatment of small coronary vessels.
    Giannini F; Latib A; Ancona MB; Costopoulos C; Ruparelia N; Menozzi A; Castriota F; Micari A; Cremonesi A; De Felice F; Marchese A; Tespili M; Presbitero P; Sgueglia GA; Buffoli F; Tamburino C; Varbella F; Colombo A
    Catheter Cardiovasc Interv; 2017 Sep; 90(3):380-386. PubMed ID: 28109036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Diabetes on Outcome With Drug-Coated Balloons Versus Drug-Eluting Stents: The BASKET-SMALL 2 Trial.
    Wöhrle J; Scheller B; Seeger J; Farah A; Ohlow MA; Mangner N; Möbius-Winkler S; Weilenmann D; Stachel G; Leibundgut G; Rickenbacher P; Cattaneo M; Gilgen N; Kaiser C; Jeger RV;
    JACC Cardiovasc Interv; 2021 Aug; 14(16):1789-1798. PubMed ID: 34412797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of large de novo coronary lesions with paclitaxel-coated balloon only: results from a Chinese institute.
    Yu X; Ji F; Xu F; Zhang W; Wang X; Lu D; Yang C; Wang F
    Clin Res Cardiol; 2019 Mar; 108(3):234-243. PubMed ID: 30074078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes with drug-coated balloons in small-vessel coronary artery disease.
    Megaly M; Rofael M; Saad M; Rezq A; Kohl LP; Kalra A; Shishehbor M; Soukas P; Abbott JD; Brilakis ES
    Catheter Cardiovasc Interv; 2019 Apr; 93(5):E277-E286. PubMed ID: 30489687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Outcomes of patients treated with drug-coated balloons for de novo large coronary vessels].
    Qiu J; Han ZY; Wang X; Lu WJ; Pan L; Sun GJ; Qin XF; Wang ZB; Liu GH; Wang XL; Qiu CG
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Jun; 47(6):452-456. PubMed ID: 31262129
    [No Abstract]   [Full Text] [Related]  

  • 15. Midterm safety and efficacy of elective drug-coated balloon angioplasty in comparison to drug-eluting stents for unrestrictive de novo coronary lesions: A single center retrospective study.
    Yamada K; Ishikawa T; Nakamura H; Mizutani Y; Ukaji T; Shimura M; Kondo Y; Aoki H; Hisauchi I; Itabashi Y; Nakahara S; Kobayashi S; Taguchi I
    J Cardiol; 2023 Jun; 81(6):537-543. PubMed ID: 36481299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison between drug-eluting stent implantation and drug-coated balloon angioplasty in patients with left main bifurcation in-stent restenotic lesions.
    Kook H; Joo HJ; Park JH; Hong SJ; Yu CW; Lim DS
    BMC Cardiovasc Disord; 2020 Feb; 20(1):83. PubMed ID: 32070287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-coated balloons for de novo coronary lesions: results from the Valentines II trial.
    Waksman R; Serra A; Loh JP; Malik FT; Torguson R; Stahnke S; von Strandmann RP; Rodriguez AE
    EuroIntervention; 2013 Sep; 9(5):613-9. PubMed ID: 24058077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neointimal Modification With Scoring Balloon and Efficacy of Drug-Coated Balloon Therapy in Patients With Restenosis in Drug-Eluting Coronary Stents: A Randomized Controlled Trial.
    Kufner S; Joner M; Schneider S; Tölg R; Zrenner B; Repp J; Starkmann A; Xhepa E; Ibrahim T; Cassese S; Fusaro M; Ott I; Hengstenberg C; Schunkert H; Abdel-Wahab M; Laugwitz KL; Kastrati A; Byrne RA;
    JACC Cardiovasc Interv; 2017 Jul; 10(13):1332-1340. PubMed ID: 28683939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second-generation drug-eluting stents versus drug-coated balloons for the treatment of coronary in-stent restenosis: A systematic review and meta-analysis.
    Kokkinidis DG; Prouse AF; Avner SJ; Lee JM; Waldo SW; Armstrong EJ
    Catheter Cardiovasc Interv; 2018 Aug; 92(2):285-299. PubMed ID: 29024274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized comparison of two paclitaxel-coated balloons for the treatment of in-stent restenosis: The LONGTY ISR China randomized trial (LONGTY DCB vs. SeQuent Please DCB).
    Hu P; Sun Y; Li CL; Jin R; Xie Q; Jiang XJ; Wu LP; Jiang JJ; Qiu XB; Cao Y; Ji G; Wang H; Yao ZH; Li B; Xia Y; Wang JA; Jiang J
    Catheter Cardiovasc Interv; 2021 May; 97 Suppl 2():988-995. PubMed ID: 33734575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.